EyewireTV — Zioptan Glaucoma Drug Approval, Eyetech Acquisition, Anti-Infectives Approval Challenges
In this week's EyewireTV, the FDA approves Zioptan, a solution to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension; and Valeant Pharmaceuticals agrees to acquire Eyetech Inc., a privately-owned ophthalmic biotechnology company specializing in the treatment of retinal diseases. In the weekly feature, ophthalmologists talk about the challenges surrounding the development of new pharmaceutical agents, such as anti-infectives, NSAIDs, and steroids, geared at improving surgical outcomes.
posted Wednesday, February 15, 2012 | 992 views
Related Videos
2/15/2012 | 992 views
EyewireTV — Zioptan Glaucoma Drug Approval, Eyetech Acquisition, Anti-Infectives Approval Challenges
In this week's EyewireTV, the FDA approves Zioptan, a solution to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension; and Valeant Pharmaceuticals agrees to acquire Eyetech Inc., a privately-owned ophthalmic biotechnology company specializing in the treatment of retinal diseases. In the weekly feature, ophthalmologists talk about the challenges surrounding the development of new pharmaceutical agents, such as anti-infectives, NSAIDs, and steroids, geared at improving surgical outcomes. Watch Video
2/8/2012 | 1,241 views
EyewireTV — Ocriplasmin Priority Review, ReSure Sealant Trial, CXL Update
In this week's EyewireTV, priority review designation is granted to ThromboGenics’ ocriplasmin for the treatment of symptomatic vitreomacular adhesion, including macular hole; and ReSure Sealant, a proprietary synthetic hydrogel polymer for ophthalmic use over clear corneal incisions, is granted investigational device exemption to conduct a pivotal clinical trial. In the weekly feature, ophthalmologists discuss the benefits of corneal collagen cross-linking and the latest studies involving epi-on and epi-off. Watch Video
2/1/2012 | 1,979 views
EyewireTV — Laser Cataract Surgery Billing, Epilepsy-Cataract Link, FDA NSAID Meeting
In this week's EyewireTV, the two largest ophthalmic medical associations partner to release controversial guidelines they say will assist ophthalmologists in determining their ability to charge Medicare and its beneficiaries for laser cataract surgery; and an upcoming FDA committee meeting will discuss clinical evidence and marketing of nonsteroidal anti-inflammatory drugs for ocular pain following cataract surgery. Watch Video
1/25/2012 | 1,698 views
EyewireTV — Stem Cell Breakthrough, Lucentis China Approval, Dry Eye Treatments
In this week's EyewireTV, human embryonic stem cells for the first time are safely used to treat macular degeneration in two patients, and Novartis receives regulatory approval in China for Lucentis as a treatment for wet AMD. In the weekly feature, cataract surgeons share their thoughts on why there is an increased focus on dry eye disease, and how it is impacting the marketplace for dry eye treatment. Watch Video
1/17/2012 | 1,586 views
EyewireTV — Generic Drug Fees, Ista Offer Increased, Medicare Eye Exam
In this week's EyewireTV, the FDA reaches an agreement that would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, and Valeant Pharmaceuticals raises its takeover offer for Ista Pharmaceuticals. In the weekly feature, leading ophthalmologists discuss what they believe the future holds for the technology behind toric and presbyopia-correcting lenses, and share tips on how to best communicate the benefits of premium lenses with patients. Watch Video
1/11/2012 | 1,582 views
EyewireTV — Aspirin/AMD Link, LASIK Corneal Cross-linking Procedure, Premium IOL Adoption
In this week’s EyewireTV, a large European study links daily aspirin use to an increased risk of age-related macular degeneration, and a proprietary brief corneal cross-linking procedure used in conjunction with LASIK receives CE Mark approval. In the weekly feature, three leading ophthalmologists identify the potential causes of the slow adoption rate of premium IOLs and advise how physicians can better communicate with patients the benefits of the premium implants. Watch Video
1/4/2012 | 1,307 views
EyewireTV — Chief Medical Editors 2012 Preview
Chief medical editors Stephen Slade, MD (Cataract & Refractive Surgery Today), and Steven D. Vold, MD (Glaucoma Today), reflect on 2011 and share their opinions on what they considered the most significant developments in their respective fields. Drs. Slade and Vold also talk about what the hottest trends and new devices will be in ophthalmology in 2012. Watch Video
12/21/2011 | 1,381 views
EyewireTV — OptiMedica Catalys FDA Approval, Takeover Bid for Ista, Online Health Grades
In this week's EyewireTV, OptiMedica Corp. has received FDA 510(k) clearance for its Catalys Precision Laser System for capsulotomy and/or lens fragmentation. Valeant Pharmaceuticals International, Inc., makes a hostile $327 million bid for Ista Pharmaceuticals Inc. In the weekly feature, experts share advice on what steps ophthalmologists should take to optimize their online presence and protect the reputation of their practice. Watch Video
12/14/2011 | 1,184 views
EyewireTV — Cross–linking Designation, Long–Term DME Study, Cataract Surgery Reimbursement
In this week's EyewireTV, the FDA grants orphan drug designation for Avedro’s riboflavin ophthalmic solution, Vibe-X, for use with its corneal cross-linking system to treat corneal ectasia following refractive surgery. In the weekly feature, ophthalmologists talk about how health care legislation may create a more competitive marketplace for the cataract surgeon and how offering premium services could help recoup losses in reimbursement. Watch Video
12/7/2011 | 1,348 views
EyewireTV — Victus CE Mark Approval, Osmolarity System Waiver, Electronic Health Records
In this week's EyewireTV, Bausch + Lomb and Technolas Perfect Vision announce that the Victus femtosecond laser platform has received CE mark approval in Europe; and the TearLab Osmolarity System overcomes a major obstacle that will allow the dry eye detection device to be more widely adopted. In the weekly feature, leading ophthalmologists talk about the discussion they would have with patients regarding charging a premium for laser cataract surgery. Watch Video
11/30/2011 | 1,248 views
EyewireTV — Eylea Approved by FDA, Diabetes/Visual Impairment Study, Health Insurance Premiums
In this week's EyewireTV, Regeneron Vice President of Medical Affairs Beate Stych skypes with EyewireTV about the benefits of Eylea, which recently received FDA approval for the treatment of wet AMD. Also, a new study reveals the percentage of people with diabetes reporting visual impairment dropped substantially over the past 14 years. Watch Video
11/16/2011 | 1,965 views
EyewireTV — Iluvien Setback, Miniature Telescope Implant, Glaucoma Screening
In this week’s EyewireTV, the FDA issues a complete response letter to Alimera stating that it is unable to approve a new drug application for Iluvien for the treatment of diabetic macular edema. In the weekly feature, ophthalmic experts discuss the advantages and disadvantages of European patients having access to technology not yet approved in the United States. Watch Video
11/9/2011 | 1,793 views
EyewireTV — FDA Drug Approvals, Retinal Prothesis, New Medical Devices
In this week's EyewireTV, the FDA releases a statement touting its pace of drug approvals in fiscal year 2011 compared with its European counterparts, and the first commercial implantation of a retinal prosthesis is successfully completed. In the weekly video feature, experts in the ophthalmic industry talk about the regulatory process of medical devices in the United States and whether barriers are causing innovation to move overseas. Watch Video
11/1/2011 | 1,491 views
EyewireTV — Childhood Vision Study, Alzheimer/Cataract Link, Product Labeling
In this week's EyewireTV, a new study reveals that a child’s vision may be affected by the amount of time spent outdoors; and patients with mild Alzheimer disease whose vision improved after cataract surgery also experienced improvements in cognitive ability, mood, sleep patterns, and other behaviors. In the weekly video feature, leading ophthalmologists discuss how increased scrutiny surrounding product labeling can affect pharmaceutical innovation and patient access to the best medicine. Watch Video
10/26/2011 | 1,557 views
EyewireTV — Laser Cataract Finances, Eye Health Survey, ORA Launch
In this week’s EyewireTV News, a new survey released by the Ocular Nutrition Society finds that baby boomers value vision more than any other sense, yet they lack knowledge about ocular health. Also, three leading ophthalmologists sit down with EyewireTV in Orlando to share their thoughts on how physicians can establish a financial model that incorporates femtosecond laser cataract technology into their practice. Watch Video
10/18/2011 | 1,241 views
EyewireTV — WebMD/B+L Partnership, OPKO sale, ACOS Summit
In this week’s EyewireTV News, WebMD Health Corp. and Bausch + Lomb announce an online educational initiative to improve eye care for patients; and OPKO Health, Inc., completes the sale of its ophthalmic instrumentation business to Optos PLC for $17.5 million. Also, ophthalmologists share their experience with EMR and EHR systems, and their advice on the best way to adopt the technology. Watch Video
10/11/2011 | 1,836 views
EyewireTV — Lucentis Price Cut, Topcon/LensAR Deal, Industry Trends
In this week’s EyewireTV News, Novartis drops the price of Lucentis by 30 percent in Switzerland after receiving pressure from the government; and Topcon Europe Medical BV makes an equity investment in LensAR. Also, three industry leaders share their thoughts on what the hottest advancements and biggest challenges to the eye care industry will be over the next 12 to 18 months. Watch Video
10/4/2011 | 1,316 views
EyewireTV — Health Care Reform Mandate, Santen Buys Novagali, LASIK Volumes
In this week’s EyewireTV News, the U.S. Department of Justice has filed a petition asking the Supreme Court to review the 2010 Affordable Care Act, which mandates Americans to purchase health insurance by 2014 or be fined. Also, three experts share their thoughts on how the global financial crisis has affected the laser refractive market, and whether LASIK volumes can bounce back to the levels of years past. Watch Video
9/27/2011 | 2,808 views
EyewireTV — VA Drops Avastin, Stem Cell Trial in Europe, Advancements in Retina
This week’s EyewireTV News, the U.S. Department of Veterans Affairs announces it will stop using bevacizumab to treat wet AMD pending the results of an investigation into its safety. Also, leading vitreoretinal surgeons share their thoughts on the most significant advancements and developments in the retinal arena, including the CATT Study, the latest data on VEGF Trap Eye, microplasmin, and the move from 20-gauge to 23- and 25-gauge microincisional surgery. Watch Video
9/20/2011 | 2,487 views
EyewireTV — Topcon/LensAR Partnership, B+L IOL Launch, Corneal Cross-linking Techniques
This week’s EyewireTV News features breaking news from the annual cataract and refractive surgery conference in Vienna, Austria, including Topcon Europe and LensAR announcing their intent to enter into a long-term strategic cooperation to distribute its femtoscond cataract laser surgery system. Also, Sheraz M. Daya, MD, of Queen Victoria Hospital, East Grinstead, United Kingdom, and A. John Kanellopoulos, MD, of Laservision Eye Institute, Athens, Greece, share their thoughts on the most effective corneal collagen cross-linking methods and techniques. Watch Video
9/13/2011 | 2,137 views
EyewireTV—Cross-linking Designation, B+L/Technolas Partnership, Tort Reform
In this week's EyewireTV News, the FDA grants Avedro Inc. orphan drug designation for its riboflavin ophthalmic solution, known as VibeX, for use with its KXL system for corneal cross-linking to treat keratoconus. Also, several top ophthalmologists share their thoughts on the need for medical malpractice reform and the impact it could have on physicians and patients. Watch Video
9/6/2011 | 2,387 views
EyewireTV- Catalys CE Mark Approval; Avastin Eye Infections; Sleep Disorder Study
In this week’s EyewireTV news, Optimedica Corp. announces that it has received CE Mark approval to market its Catalys Precision Laser System for cataract surgery in Europe; and the FDA is alerting health care professionals that repackaged intravitreal injections of Avastin have caused several cases of serious eye infections. Watch Video
8/30/2011 | 1,717 views
EyewireTV—Pediatric Study, Implantable Miniature Telescope, Pattern Scan Laser
In this week’s EyewireTV news, a pediatric study of more than 10,000 children show large variations in the number of children with myopia, hyperopia, and astigmatism; and ophthalmic leaders discuss whether European patients have an advantage in having access to newer technology not yet available in the US. Watch Video
8/23/2011 | 1,491 views
EyewireTV - EYLEA FDA Extension, New PASCAL System, Integrated Medicine
In this week’s EyewireTV news feature, John Doane, MD, of Discover Vision Centers in Kansas City, Missouri, and Mark Kontos, MD, a partner of Empire Eye Physicians of Washington and Idaho, discuss the importance of integrated healthcare in today's eye care environment, and how to prepare your practice for the influx of patients that will result from the aging baby boom population. Watch Video
8/16/2011 | 1,127 views
Welcome to the EyewireTV Weekly News Broadcast
Anchorwoman Devyn Gehret provides the most relevant and timely ophthalmic stories of the past week, and Drs. Stephen Slade and Steven Dell sit down with Eyewire News Editor Stephen Daily to discuss the future of femtosecond laser cataract surgery. Watch Video
Advertisement
- Glaucoma Specialist/ Catarat Surgeon
CT (Statewide)
Glaucoma Specialist/Cataract Surgeon, ConnecticutBeautiful office in the middle of a suburban town center that provides complete medical and surgical eye care for the entire family. Practice sees 25,000 patients per year...
